$1.09 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 25 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VG | Sell | VONAGE HLDGS CORP | $60,166,000 | -33.0% | 8,321,732 | -31.4% | 5.50% | -21.0% |
| ITRI | Sell | ITRON INC | $56,209,000 | -63.9% | 1,006,793 | -45.8% | 5.14% | -57.4% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $37,452,000 | -59.1% | 1,264,402 | -50.0% | 3.43% | -51.7% |
| RTRX | Sell | RETROPHIN INC | $25,349,000 | -11.3% | 1,737,434 | -13.6% | 2.32% | +4.7% |
| AMSC | Exit | AMERICAN SUPERCONDUCTOR CORP | $0 | – | -17,945 | -100.0% | -0.01% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -902,277 | -100.0% | -0.09% | – |
| FOSL | Exit | FOSSIL GROUP INC | $0 | – | -384,772 | -100.0% | -0.24% | – |
| PSEC | Exit | PROSPECT CAPITAL CORPORATION | $0 | – | -1,008,841 | -100.0% | -0.50% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -54,942 | -100.0% | -0.53% | – |
| SPY | Exit | SPDR S&P 500 ETF TRtr unit | $0 | – | -31,033 | -100.0% | -0.77% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -739,479 | -100.0% | -1.02% | – |
| HHR | Exit | HEADHUNTER GROUP PLCsponsored ads | $0 | – | -1,471,241 | -100.0% | -2.45% | – |
| BA | Exit | BOEING COput | $0 | – | -116,500 | -100.0% | -2.94% | – |
| UPWK | Exit | UPWORK INC | $0 | – | -3,791,520 | -100.0% | -3.14% | – |
| WBT | Exit | WELBILT INC | $0 | – | -2,783,669 | -100.0% | -3.37% | – |
| NXPI | Exit | NXP SEMICONDUCTORS N V | $0 | – | -407,438 | -100.0% | -4.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
| ISHARES TR | 28 | Q3 2023 | 10.9% |
| MANNKIND CORP | 24 | Q3 2023 | 0.5% |
| BAIDU INC | 21 | Q2 2018 | 8.6% |
| ITRON INC | 21 | Q3 2020 | 12.1% |
| RETROPHIN INC | 20 | Q3 2020 | 4.5% |
| HARMONIC INC | 19 | Q3 2023 | 10.5% |
| JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
| ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
| Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
| Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
| Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
| ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
| ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
| ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
| Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
| GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13D | 2024-04-26 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-01-22 |
| 13F-HR/A | 2023-11-14 |
| 13F-HR | 2023-11-14 |
| SC 13D | 2023-09-21 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.